Armenia vs Laos: Cause of death, by non-communicable diseases, ages 15-59, male
Armenia
62.7%
in 2021
Laos
60.5%
in 2021
Armenia rank
56th
Laos rank
58th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Armenia
- Laos
How they compare
Armenia currently reports 62.7% against 60.5% in Laos, a difference of 2.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Armenia ahead.
Armenia ranks 56th and Laos ranks 58th of 185 countries.
Across the 3 decades both report, Armenia averaged higher in 2 and Laos in 1.
Head to head by decade
| Decade | Armenia | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.1% | 50.6% | 23.5% | Armenia |
| 2010s | 75.4% | 58.8% | 16.6% | Armenia |
| 2020s | 50.6% | 62.9% | 12.3% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Armenia or Laos?
- Armenia, at 62.7% against 60.5% in Laos as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Armenia and Laos?
- 2.2%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Laos?
- 6 years are reported by both, from 2000 to 2021.
- How do Armenia and Laos rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Armenia ranks 56th and Laos ranks 58th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.